Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NP-G2-044PrilukaePhase 32 trials
Novita Pharmaceuticals, Inc. · Platinum-resistant Ovarian Cancer, Advanced or Metastatic Solid Tumor Malignancies
- NRTX-1001GABA-secreting interneuronsPhase 32 trials
Neurona Therapeutics · Epilepsy, Temporal Lobe, Mesial Temporal Lobe Epilepsy
- NTLA-2001nexiguran ziclumeranPhase 32 trials
Intellia Therapeutics · Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease
- NucresiranALN-TTRSC04Phase 32 trials
Alnylam Pharmaceuticals · Transthyretin Amyloidosis With Cardiomyopathy, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN
- NuvastaticPhase 32 trials
Natureceuticals Sdn Bhd · Fatigue, Colon Cancer, Breast Neoplasms
- Nuvastatic 300Phase 32 trials
Natureceuticals Sdn Bhd · Fatigue Related to Cancer Treatment, Colon Cancer, Breast Cancer
- NVG-291Phase 32 trials
NervGen Pharma · Chronic Spinal Cord Injury, Spinal Cord Injuries, Subacute Spinal Cord Injury
- NXT007Zemocimig, RO7589655Phase 32 trials
Roche (Genentech) · Hemophilia A
- OBI-821OBI-833Phase 32 trials
OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer
- OBRPhase 32 trials
Gilead Sciences · HIV-1-infection
- OciperlimabBGB-A1217Phase 32 trials
BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies
- OCS-01Phase 32 trials
Oculis · Diabetic Macular Edema
- of Physician's ChoicePhase 32 trials
BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm
- OlorofimF901318Phase 32 trials
F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection
- OLZSAM, ALKS 3831Phase 32 trials
Alkermes, Inc. · Bipolar I Disorder, Schizophrenia
- ONO-2808Phase 32 trials
Ono Pharmaceutical Co., Ltd. · Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy (MSA)
- Open-Label Extension PLS240Phase 32 trials
Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease
- OPN-375Phase 32 trials
Optinose US Inc. · Chronic Rhinosinusitis Without Nasal Polyps, Bilateral Nasal Polyposis
- OSE2101Phase 32 trials
OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma
- PalazestrantOP-1250Phase 32 trials
Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
- PamiparibBGB-290Phase 32 trials
BeOne Medicines (BeiGene) · Ovarian Cancer, Advanced Malignancies
- PBOPhase 32 trials
SK Life Science, Inc. · Primary Generalized Epilepsy, Treatment Resistant Depression
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- PF-08046054SGN-PDL1VPhase 32 trials
Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
- phentolamine vehiclePhase 32 trials
Opus Genetics, Inc · Mesopic Vision, Night Vision Loss, Presbyopia
- PicankibartPhase 32 trials
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis
- piclidenosonPhase 32 trials
Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome
- pMDI HFA-152aCHF5993 100, CHF5993 200Phase 32 trials
Chiesi Farmaceutici S.p.A. · Asthma
- PORT-77Phase 32 trials
Portal Therapeutics, Inc. · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2
- Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials
EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer
- PridopidinePhase 32 trials
Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease
- PTM FPhase 32 trials
Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection
- PTM LENPhase 32 trials
Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection
- PTX-022Phase 32 trials
Palvella Therapeutics, Inc. · Angiokeratomas, Pachyonychia Congenita
- pudexacianinium chlorideASP5354Phase 32 trials
Astellas · Intraoperative Ureter Visualization, Abdominolpelvic Surgery
- Purinostat MesylatePhase 32 trials
Chengdu Zenitar Biomedical Technology Co., Ltd · Relapsed or Refractory Multiple Myeloma (RRMM), Recurrent and Refractory Diffuse Large B-cell Lymphoma
- Qishen Yiqi Dripping Pills 2 bagsPhase 32 trials
Tasly Pharmaceutical Group Co., Ltd · Heart Failure, Chronic Heart Failure With Preserved Ejection Fraction
- QL0911Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune
- QLS32015Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Relapsed or Refractory Multiple Myeloma
- QLS4131Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma
- QRX-3EseronatePhase 32 trials
Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure
- QTORIN 3.9% rapamycin anhydrousPhase 32 trials
Palvella Therapeutics, Inc. · Cutaneous Venous Malformations, Microcystic Lymphatic Malformation
- RadiprodilPhase 32 trials
GRIN Therapeutics, Inc. · GRIN-related Neurodevelopmental Disorder, Tuberous Sclerosis Complex, Focal Cortical Dysplasia
- RalinepagAPD811Phase 32 trials
United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension
- RC118RC118-ADCPhase 32 trials
RemeGen Co., Ltd. · Advanced Solid Tumor, Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Reference DrugNSAIDsPhase 32 trials
SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis
Sun Pharmaceutical Industries, Inc. · Actinic Keratosis
- REGEND001Phase 32 trials
Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis
- REGN1908FreneslerbartPhase 32 trials
Regeneron · Allergic Conjunctivitis
- REGN1909MevonlerbartPhase 32 trials
Regeneron · Allergic Conjunctivitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.